1. Emergence of Methicillin-Resistant Staphylococcus aureus with Intermediate Glycopeptide Resistance

   • Michael J. Rybak
   • Ronda L. Akins

   Current Opinion 25 September 2012 Pages: 1 - 7

   

2. The Role of Fluoroquinolones in Tuberculosis Today

   • Shaun E. Berning

   Leading Article 25 September 2012 Pages: 9 - 18

   

3. The Emerging Roles of Non-Nucleoside Reverse Transcriptase Inhibitors in Antiretroviral Therapy

   • Graeme Moyle

   Leading Article 25 September 2012 Pages: 19 - 26

   

4. Response to Inhaled Nitric Oxide in Premature and Term Neonates

   • Thomas Hoehn
   • Martin F. Krause

   Review Article 25 September 2012 Pages: 27 - 39

   

5. Cholinesterase Inhibitors for Alzheimer’s Disease

   • Jaime Grutzendler
   • John C. Morris

   Review Article 25 September 2012 Pages: 41 - 52

   

6. Treatments for Androgenetic Alopecia and Alopecia Areata

   • Victor M. Meidan
   • Elka Touitou

   Therapy in Practice 25 September 2012 Pages: 53 - 69

   

7. Inhaled Budesonide/Formoterol Combination

   • Jane K. McGavin
   • Karen L. Goa
   • Blair Jarvis

   Adis New Drug Profile 25 September 2012 Pages: 71 - 78

   

8. Budesonide/Formoterol Combination

   • Louis-Philippe Boulet

   Adis New Drug Profile 25 September 2012 Pages: 79 - 79

9. Budesonide/Formoterol Combination

   • Brian J. Lipworth

   Adis New Drug Profile 25 September 2012 Pages: 79 - 80

10. Fluoxetine

    • Susan M. Cheer
    • Karen L. Goa

    Adis Drug Evaluation 25 September 2012 Pages: 81 - 110

    

11. Olanzapine

    • Nila Bhana
    • Rachel H. Foster
    • Greg L. Plosker

    Adis Drug Evaluation 25 September 2012 Pages: 111 - 161